These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34753175)

  • 21. Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.
    Villena R; Valenzuela MT; Bastías M; Santolaya ME
    Vaccine; 2022 Jan; 40(4):666-672. PubMed ID: 34996641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global practices of meningococcal vaccine use and impact on invasive disease.
    Ali A; Jafri RZ; Messonnier N; Tevi-Benissan C; Durrheim D; Eskola J; Fermon F; Klugman KP; Ramsay M; Sow S; Zhujun S; Bhutta Z; Abramson J
    Pathog Glob Health; 2014 Jan; 108(1):11-20. PubMed ID: 24548156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.
    Parikh SR; Campbell H; Bettinger JA; Harrison LH; Marshall HS; Martinon-Torres F; Safadi MA; Shao Z; Zhu B; von Gottberg A; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Oct; 81(4):483-498. PubMed ID: 32504737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
    Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
    Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City.
    Simon MS; Weiss D; Geevarughese A; Kratz MM; Cutler B; Gulick RM; Zucker JR; Varma JK; Schackman BR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):146-54. PubMed ID: 26334735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia.
    Marshall HS; Lally N; Flood L; Phillips P
    Med J Aust; 2020 Feb; 212(2):89-93. PubMed ID: 31909501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada.
    De Wals P; Zhou Z
    Pediatr Infect Dis J; 2017 Jul; 36(7):e203-e207. PubMed ID: 28027288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential public health impact of a
    Huang L; Snedecor SJ; Balmer P; Srivastava A
    Postgrad Med; 2022 May; 134(4):341-348. PubMed ID: 33615973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines.
    Pelton SI
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S3-S11. PubMed ID: 27449148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of invasive meningococcal disease in the south of Brazil: considerations of immunization programme.
    Silveira MM; Crespo da Silva PA; Conrad NL; Oliveira TL; Hartwig DD; Trotter C
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33544069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningococcal infections among refugees and immigrants: silent threats of past, present and future.
    Dinleyici EC; Borrow R
    Hum Vaccin Immunother; 2020 Nov; 16(11):2781-2786. PubMed ID: 32347773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.
    Taha MK; Martinon-Torres F; Köllges R; Bonanni P; Safadi MAP; Booy R; Smith V; Garcia S; Bekkat-Berkani R; Abitbol V
    Expert Rev Vaccines; 2022 May; 21(5):659-674. PubMed ID: 35271781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.
    Lingappa JR; Rosenstein N; Zell ER; Shutt KA; Schuchat A; Perkins BA;
    Vaccine; 2001 Aug; 19(31):4566-75. PubMed ID: 11483285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing invasive meningococcal disease in early infancy.
    Presa J; Serra L; Weil-Olivier C; York L
    Hum Vaccin Immunother; 2022 Nov; 18(5):1979846. PubMed ID: 35482946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of meningococcal C conjugate vaccine on incidence of invasive meningococcal disease in an 18-year time series in Brazil and in distinct Brazilian regions.
    Cruz MC; Camargos P; Nascimento-Carvalho CM
    Trop Med Int Health; 2022 Mar; 27(3):280-289. PubMed ID: 34997999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of surveillance: Group W meningococcal disease outbreak response and control in England.
    Campbell H; Ladhani S
    Int Health; 2016 Nov; 8(6):369-371. PubMed ID: 27620924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.
    Hellenbrand W; Koch J; Harder T; Bogdan C; Heininger U; Tenenbaum T; Terhardt M; Vogel U; Wichmann O; von Kries R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1314-43. PubMed ID: 26487381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.